Official Title
Effects of Non-invasive Neuromodulation on Post-COVID-19 Syndrome: Multicenter Study
Brief Summary

The aim of this study is to analyse whether there is an advantage in adding low-intensityelectrical stimulations to the vagus nerve with electrodes in the outer ear to controlpain and fatigue in people with primary chronic pain, and in people who have hadCOVID-19. Several studies have shown that many people with primary chronic pain and alsopeople who have had COVID patients continue to have pain and fatigue that may be due tochanges that occur in the brain and the vagus nerve that passes through the neck mightcause inflammation. Therefore the aim of this study is to investigate if these electricalstimulations can help improve the condition of the brain and nerve and consequently, theinflammation so that these complaints improve.This study will be organized as the following: It will begin with an assessment, dividedinto a part with questionnaires and another with specific tests. The questionnaires areaimed at understanding volunteer's characteristics, pain, fatigue, inflammation, sleep,quality of life, and the presence of symptoms of anxiety and depression. Next, thevolunteer will undergo two tests to assess the behavior of his/her brain. They areperformed using EEG electroencephalography and transcranial magnetic stimulation (TMS). - Quantitative EEG at rest - In this technique, a cap with electrodes is placed on volunteer's head, in contact with hair, which are connected through a gel. The volunteer needs to remain still for 6 minutes with eyes closed, sitting in a comfortable chair. - TMS with EEG - First, the volunteer will be asked to honestly answer the questions in the safety questionnaire for using this technique. Honest answers will eliminate the risks associated with this evaluation. Next, the volunteer's skin will be cleaned with alcohol and a special paste and place three self-adhesive electrodes on the muscle of the volunteer's hand, in a muscle called the interosseous, on the side where he/she writes. These electrodes will only capture the electrical activity of the muscle. Next, a series of magnetic pulses will be administered to the volunteer's skull, in the area that controls the hand muscle. It will contract with each pulse and, with this, so that the functioning of this connection can be understood. At the same time, the EEG device will capture the brain activities that occur during this TMS stimulation. During this exam, the volunteer may feel anything from no stimulation to muscle contractions that move his/her hand. Some people also experience redness under the electrodes, fatigue, or muscle/joint pain.After the assessments, volunteers will be randomly selected to receive neuromodulationsessions using low-intensity electrical stimulation of the vagus nerve, using electrodesin the outer ear (active group), or sessions that only simulate this neuromodulation(sham, or placebo, group). This will occur for five consecutive days, starting on the dayof the assessment. This stimulation is very weak and may not even be felt by the personreceiving it. This technique is safe and the most that may occur is redness or itching ofthe skin. A few people may also experience tingling, a burning sensation or momentarylocal pain, fatigue, drowsiness, difficulty concentrating and a feeling of nervousnessduring or after the stimulation.At the end of the 5 days of electrical stimulation, the same initial assessments will berepeated to see if anything has changed in the volunteer's brain, heart rate, bloodpressure, pain, fatigue, inflammation, sleep, quality of life, depression, and anxiety.

Detailed Description

Not Provided

Enrolling by invitation
Post COVID Condition
Chronic Pain
Healthy

Device: taVNS - transauricular vagal nerve stimulation

30 minutes of electrical stimulation on the afferent portion of the vagal nerve on the
cymba conchae of the ear, in the following configuration: 30 seg ramp up, 30 seg on, 30
seg off in intensity on which the volunteer feels a light tingling.

Device: rPMS - repetitive peripheric magnetic stimulation

Magnetic stimulation on the efferent portion of the vagal nerve on the neck, on the
following configuration: 20Hz, 25 pulses in the trein, in every inhalation, for 20
inhalations with 50% of machine capacity (500 pulses total).

Device: rTMS - repetitive transcranial magnetic stimulation

rTMS intermitent theta- burst on the left DLPFC, on the following configuration: 50 Hz in
treins of 5Hz, with 110% of the resting motor limiar and 600 pulses in 3 minutes.

Device: taVNS sham

Simulated taVNS (SHAM) on helix left ear, that is the same as taVNS, but during only 1
minute

Eligibility Criteria

Inclusion Criteria:

- Healthy individuals, both sexes, aged between 18 and 40 years (first arm).

- Diagnosis of primary chronic pain (for more than 3 months), such as fibromyalgia
(chronic widespread pain), primary chronic headache and orofacial pain, chronic
primary visceral pain, post-COVID pain, and chronic primary musculoskeletal pain;

- In the case of post-COVID-19 pain, the symptoms must be present for at least 12
weeks. The complaints of pain, fatigue, and/or changes in mental health should have
started after infection by SARS-Cov-2.

Exclusion Criteria:

- Individuals who present dysautonomia;

- obese individuals with a high abdominal fat index characterized by a waist/hip ratio
of 0.80 for women and 0.95 for men;

- heart disease;

- diabetes mellitus;

- vestibular alterations characterized by the Dix-Hallpike maneuver, supine rotation
test, arc test, side-lying maneuver, and post-head-shake nystagmus;

- diagnosis of epilepsy or first-degree family history of epilepsy

- fever;

- chronic consumption of alcohol, or other recreational drugs;

- presence of contraindications for the use of non-invasive neuromodulation;

- those who become ill with COVID-19 during the data collection period;

- those who are unable to answer the evaluation questionnaires;

- those with clinical instability;

- those who have a previous history of chronic pain or fatigue before contracting
COVID-19;

- those who have neuropathic pain.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 64 Years
Countries
Brazil
Locations

Federal University of ABC
Sâo Bernardo do Campo, Sao paulo, Brazil

Tiago S Lopes, PhD, Study Chair
Federal University of ABC

Federal University of ABC
NCT Number
Keywords
neuromodulation
Chronic Pain
Covid-19
TMS-EEG
vagal nerve
MeSH Terms
COVID-19
Chronic Pain